New antibodies as adjunctive therapies for Gram-positive bacterial meningitis.
Tuomanen
E
E
Rockefeller University, New York.
Baruch
A
A
D000818:Animals; D001424:Bacterial Infections / Q000628:therapy*; D002473:Cell Wall / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000166:cytology; D006094:Gram-Positive Bacteria; D007116:Immunization, Passive; D007375:Interleukin-1 / Q000502:physiology; D007962:Leukocytes / Q000276:immunology; D008581:Meningitis / Q000628:therapy*; D008586:Meningitis, Pneumococcal / Q000628:therapy*; D013296:Streptococcus pneumoniae / Q000378:metabolism / Q000648:ultrastructure; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha